Original Contributions |
From the Institutes of Traditional Medicine (Y.-J.W., C.-Y.H.) and Clinical Medicine (S.-J.L., C.-Y.H.), National Yang-Ming University; and the Departments of Medical Research and Education (M.-S.S.) and Internal Medicine (C.-Y.H., S.-J.L., P.W.), Veterans General Hospital, Taipei, Taiwan, ROC.
Correspondence to Ming-Shi Shiao, Department of Medical Research and Education, Veterans General Hospital-Taipei, 201, Section 2, Shih-pai Road, Taipei, Taiwan 11217, Republic of China.
AbstractAntioxidants that prevent LDL from oxidation may reduce atherosclerosis. Salvia miltiorrhiza Bunge is a Chinese herb widely used for the treatment of atherosclerosis-related disorders. Salvianolic acid B (Sal B), a water-soluble polyphenolic antioxidant isolated from the roots of this plant, was found to scavenge 1,1-diphenyl-2-picrylhydrazyl radicals and inhibit LDL oxidation more effectively than probucol. In order to evaluate the antiatherogenic potential, New Zealand White rabbits were fed for 12 weeks a normal diet, a high cholesterol diet, a high cholesterol diet containing 1% probucol, or a high cholesterol diet containing a 5% water-soluble extract of S miltiorrhiza (SM). Both SM and probucol feeding reduced plasma cholesterol. LDLs from the SM-treated group were more resistant to Cu2+-induced oxidation and contained more vitamin E (21.7±2.1 nmol/µmol LDL cholesterol) than did LDLs from the high cholesterol diet group (9.6±1.8 nmol/µmol LDL cholesterol) (P<.005). Endothelial damage, determined at week 6, was reduced by 53% in the SM group (P<.01). SM treatment reduced the atherosclerotic area in the abdominal aorta by 56% (P<.005) and cholesterol deposition in the thoracic aorta by 50% (P<.005). The severity of atherosclerosis in the SM group was significantly reduced after adjustment by using cholesterol exposure as an index of the cholesterol-lowering effect. This study concludes that the reduction of atherosclerosis by SM relies not only on its cholesterol-lowering effect but more heavily on its antioxidant potential to prevent endothelial damage and inhibit LDL oxidative modification in hypercholesterolemic animals.
Key Words: Salvia miltiorrhiza salvianolic acid B vitamin E atherosclerosis oxidized LDL
This article has been cited by other articles:
![]() |
L. Zhou, Z. Zuo, and M. S. S. Chow Danshen: An Overview of Its Chemistry, Pharmacology, Pharmacokinetics, and Clinical Use J. Clin. Pharmacol., December 1, 2005; 45(12): 1345 - 1359. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Valli and E.-G. V. Giardina Benefits, adverse effects and drug interactionsof herbal therapies with cardiovascular effects J. Am. Coll. Cardiol., April 3, 2002; 39(7): 1083 - 1095. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Weiss, J. J. Kools, and W. R. Taylor Angiotensin II-Induced Hypertension Accelerates the Development of Atherosclerosis in ApoE-Deficient Mice Circulation, January 23, 2001; 103(3): 448 - 454. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Xing, J. Baffic, and C. P. Sparrow LDL oxidation by activated monocytes: characterization of the oxidized LDL and requirement for transition metal ions J. Lipid Res., November 1, 1998; 39(11): 2201 - 2208. [Abstract] [Full Text] |
||||
|
ATVB Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1998 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |